Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
5.64
-0.38 (-6.40%)
At close: Apr 28, 2026, 4:00 PM EDT
5.62
-0.02 (-0.33%)
After-hours: Apr 28, 2026, 4:07 PM EDT
Kalaris Therapeutics Market Cap
Kalaris Therapeutics has a market cap or net worth of $129.20 million as of April 28, 2026. Its market cap has decreased by -5.50% in one year.
Market Cap
129.20M
Enterprise Value
12.67M
1-Year Change
-5.50%
Ranking
Category
Stock Price
$5.64
Market Cap Chart
Since March 19, 2025, Kalaris Therapeutics's market cap has decreased from $214.52M to $129.20M, a decrease of -39.77%. That is a compound annual growth rate of -36.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 138.03M | -12.56% |
| Dec 31, 2025 | 157.85M | -26.42% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galectin Therapeutics | 153.38M |
| Alps Group | 149.76M |
| Agenus | 149.75M |
| TuHURA Biosciences | 149.41M |
| Alpha Cognition | 149.26M |
| Spruce Biosciences | 146.92M |
| Tenaya Therapeutics | 145.87M |
| Connect Biopharma Holdings | 142.43M |